Anthony Digiandomenico - Net Worth and Insider Trading
Anthony Digiandomenico Net Worth
The estimated net worth of Anthony Digiandomenico is at least $5 Million dollars as of 2024-05-12. Anthony Digiandomenico is the Director of Provention Bio Inc and owns about 178,712 shares of Provention Bio Inc (PRVB) stock worth over $4 Million. Anthony Digiandomenico is the Director of Cue Biopharma Inc and owns about 57,000 shares of Cue Biopharma Inc (CUE) stock worth over $99,180. Anthony Digiandomenico is also the Director of ENDRA Life Sciences Inc and owns about 102,434 shares of ENDRA Life Sciences Inc (NDRA) stock worth over $30,628. Details can be seen in Anthony Digiandomenico's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Anthony Digiandomenico has not made any transactions after 2023-05-02 and currently still holds the listed stock(s).
Transaction Summary of Anthony Digiandomenico
Anthony Digiandomenico Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anthony Digiandomenico owns 7 companies in total, including ENDRA Life Sciences Inc (NDRAU) , Provention Bio Inc (PRVB) , and Cue Biopharma Inc (CUE) among others .
Click here to see the complete history of Anthony Digiandomenico’s form 4 insider trades.
Insider Ownership Summary of Anthony Digiandomenico
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NDRAU | ENDRA Life Sciences Inc | 2020-07-21 | director |
| PRVB | Provention Bio Inc | 2019-09-30 | director |
| CUE | Cue Biopharma Inc | 2018-12-28 | director |
 | | 2004-08-06 | director |
| | 2004-12-17 | director |
| | 2023-05-02 | director |
| | 2023-07-25 | director & 10 percent owner & Chief of Transactions |
Anthony Digiandomenico Latest Holdings Summary
Anthony Digiandomenico currently owns a total of 3 stocks. Among these stocks, Anthony Digiandomenico owns 178,712 shares of Provention Bio Inc (PRVB) as of September 30, 2019, with a value of $4 Million and a weighting of 97.17%. Anthony Digiandomenico owns 57,000 shares of Cue Biopharma Inc (CUE) as of December 28, 2018, with a value of $99,180 and a weighting of 2.16%. Anthony Digiandomenico also owns 102,434 shares of ENDRA Life Sciences Inc (NDRA) as of May 2, 2023, with a value of $30,628 and a weighting of 0.67%.
Latest Holdings of Anthony Digiandomenico
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRVB | Provention Bio Inc | 2019-09-30 | 178,712 | 24.98 | 4,464,226 |
| CUE | Cue Biopharma Inc | 2018-12-28 | 57,000 | 1.74 | 99,180 |
| NDRA | ENDRA Life Sciences Inc | 2023-05-02 | 102,434 | 0.30 | 30,628 |
Holding Weightings of Anthony Digiandomenico
Anthony Digiandomenico Form 4 Trading Tracker
According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 7 transactions in Provention Bio Inc (PRVB) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Provention Bio Inc is the acquisition of 30,000 shares on September 30, 2019, which cost Anthony Digiandomenico around $204,900.
According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 0 transactions in Cue Biopharma Inc (CUE) over the past 5 years. The most-recent trade in Cue Biopharma Inc is the acquisition of 7,000 shares on December 28, 2018, which cost Anthony Digiandomenico around $32,340.
According to the SEC Form 4 filings, Anthony Digiandomenico has made a total of 4 transactions in ENDRA Life Sciences Inc (NDRA) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in ENDRA Life Sciences Inc is the acquisition of 83,333 shares on May 2, 2023, which cost Anthony Digiandomenico around $100,000.
Insider Trading History of Anthony Digiandomenico
- 1
Anthony Digiandomenico Trading Performance
GuruFocus tracks the stock performance after each of Anthony Digiandomenico's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anthony Digiandomenico is 24.91%. GuruFocus also compares Anthony Digiandomenico's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anthony Digiandomenico within 3 months outperforms 15 times out of 25 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anthony Digiandomenico's insider trading performs compared to the benchmark.
Performance of Anthony Digiandomenico
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.01 | | | | | |
| Relative Return to S&P 500(%) | 4.32 | | | | | |
Anthony Digiandomenico Ownership Network
Anthony Digiandomenico Owned Company Details
What does ENDRA Life Sciences Inc do?
Who are the key executives at ENDRA Life Sciences Inc?
Anthony Digiandomenico is the director of ENDRA Life Sciences Inc. Other key executives at ENDRA Life Sciences Inc include Chief Commercial Officer Renaud Bertrand Maloberti , Chief Technology Officer Michael Milos Thornton , and Chief Financial Officer David R. Wells .
ENDRA Life Sciences Inc (NDRAU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ENDRA Life Sciences Inc (NDRAU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ENDRA Life Sciences Inc (NDRAU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ENDRA Life Sciences Inc (NDRAU)'s detailed insider trading history can be found in Insider Trading Tracker table.
ENDRA Life Sciences Inc Insider Transactions
Anthony Digiandomenico Mailing Address
Above is the net worth, insider trading, and ownership report for Anthony Digiandomenico. You might contact Anthony Digiandomenico via mailing address: 3600 Green Court, Suite 350, Ann Arbor Mi 48105.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
